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A lipotropic substance, as defined by Best et al.,16 is one which
decreases the rate of deposition and accelerates the rate of removal
ofliver fat. More recentlyemphasis has been placed on the preven-
tion of fat deposition rather than on decrease in rate of deposition.
Lipotropic action of choline
In 1924 Allan, Bowie, Macleod, and Robinson' reported that
depancreatized dogs receivingadequate amounts of insulin and main-
tained on a diet of lean meat, sucrose, and bone ash did not survive
for periods of longer than a few months. They also observed that
symptoms of failure of liver function due to fat infiltration of the
liver found in such animals could be prevented by adding raw
pancreas to the diet. They suggested, therefore, that the pancreas
might possibly produce an internal secretion necessary for the physi-
ological integrity of the liver. In 1930 and 1931 Hershey56 and
Hershey and Soskin57 found that crude egg-yolk lecithin could suc-
cessfully replace raw pancreas in the diet of the depancreatized dog.
Attention was temporarily withdrawn from the study of the fatty
liver of the depancreatized dog by the discovery by Best et al."3 that
the development of fatty livers in rats fed on a high fat diet could
be prevented by the addition oflecithin tothe diet. The application
of this relatively simple type of experiment, that is, the use of rats
fed on a diet of mixed grain and containing 40% beef fat, in
place of the use of the depancreatized dog, led to rapid progress in
the field. The first step in the development was made by Best and
Huntsman"4 when they found that choline was the active agent in
lecithin which prevented the accumulation of liver fat. Subsequent
work by Best, Channon, and Ridout" on fractionation of the liver
fat revealed that the fatty liver caused by feeding diets high in fat
was occasioned entirely by an increase in the neutral fat fraction with
no effect on the cholesterol or phospholipid fractions, and they also
obtained confirmation of the action of choline in preventing such
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accumulation. The curative effect of choline was next demonstrated
when Best and Huntsman"Z observed that the livers of rats which
had been on the high fat diet for 3 weeks, and which contained
15% fat, could be restored to a normal fat content (4 to 5%) in 3
weeks by the daily addition to the diet of 70 mg. of choline.
Choline and "cholesterol" fatty liver
In 1932 Blatherwick et al.24 fed to rats diets containing raw liver
or dried whole liver and observed that these animals developed fatty
livers containing large amounts of cholesteryl esters and fatty acids,
but with no increased content of lecithin. In the following year
they reported that the addition of 1%7 of cholesterol to diets other-
wise without effect on the liver caused the production of fatty livers.
Similar results were reported in 1933 by Chanutin and Ludewig,34
and have been amply confirmed by other workers. Channon and
Best refer to this type of dietary fatty liver as "cholesterol" fatty
liver, as contrasted with the "fat" fatty liver produced by feeding
diets high in fat. Best, Channon, and Ridout11 produced "choles-
terol" fatty liver in rats by administration of a diet containing grain,
fat, and cholesterol in the ratio of 80: 20: 2 for about 3 weeks, after
which time fractionation of the liver fats showed an increase in the
neutral fat fraction, but a more striking increase was observed in the
cholesteryl esters. The addition of choline to the diet prevented
the accumulation of the neutral fat but only partially prevented the
accumulation of cholesteryl esters, the content being about 60% less
than that resulting from the same diet without the choline.
Further work by Best and Channon"0 and by Best and Ridout"9
on the effect of choline on the "cholesterol" fatty liver has demon-
strated the following points: (1) Choline prevents the accumulation
of glyceride and causes removal of that already present in the
"cholesterol" fatty liver, but the degree to which this effect is
obtained depends to some extent on the initial glyceride concentra-
tion, the effect being more marked when the initial level is high.
(2) The effects on the cholesterol fraction are much less pronounced
than on the neutral fat fraction. (3) The duration of the test period
is very important. In short experiments choline may show no effect
on cholesteryl esters. (4) The dose of choline required to influence
cholesteryl esters is greater than for a comparable effect on glycer-
ides. The conclusion may therefore be drawn that the effect of
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choline on glycerides precedes that on cholesteryl esters, but it
cannot be definitely stated that the effect of choline on cholesteryl
esters is only an indirect one through reduction of the glycerides,
because it has been shown that the neutral fat need not necessarily
be reduced to very low levels before the effect on cholesteryl esters
is observed, and further, under certain conditions choline may cause
the glyceride level to fall while thecholesteryl esters are increasing.19
In 1938 Loizides,60 working in Channon's laboratory, investi-
gated the effect of varying amounts of dietary fat on the lipids of
"cholesterol" fatty livers. He found that successive increases in the
percentage of fat in the diet caused progressive and large increases
in the amount of cholesteryl esters as well as of glycerides in the
liver. He suggests that this may be caused by increased absorption
of cholesterol with increased fat intake but he was unable to obtain
conclusive evidence on this point.
Choline and non-dietary fatty livers
Best et al.17 investigated the effect of choline on the fatty livers
of rats poisoned with phosphorus, and observed that it increased the
rate of disappearance of fat during the recovery phase but did not
inhibit its formation. Further, Barrett et al.5 found that the devel-
opment of fatty livers in rats on a diet low in choline and given
carbon tetrachloride could be prevented by the inclusion of excess
choline in the diet. As will be discussed in detail later, choline also
exerts a lipotropic action on the fatty livers of depancreatized dogs.
IThus, the widespread derivations of fatty livers against which choline
is effective indicate its intimate relation with the processes of fat
metabolism.
Basal diets
Before further discussion on lipotropic substances can be profit-
ably pursued it is necessary to consider the basal diets used in experi-
mental work. This is an extremely important and complicated
problem, because, in addition to the lipotropic action of small
amounts of choline, it has been shown that proteins and various
members of the vitamin-B complex have pronounced effects on fat
metabolism, points which will be discussed in some detail later.
As has already been stated, the original diet used by Best for
producing fatty livers contained a mixture of grains, and it was soon
noticed that considerable amounts of choline were present. In
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order to help in the elimination of this and possibly other unknown
lipotropic factors Best introduced a basal diet which he has continued
to use throughout most of his experimental work. This diet consists
of meat powder (made by extracting beef musde with strong alco-
hol) 10%, beef fat 40%, sucrose 43%o, salt mixture 5%, and agar
2%, with additions ofvitamins A and D as cod-liver oil, and crystal-
line vitamin B1. A drawback to this diet, which has been shown to
be choline-free, is in the uncertain nature of the meat powder. The
basal diet used by Channon is essentially the same except that he
uses a purified casein in place of the meat powder, glucose in place
of sucrose, and he includes 5% marmite (a yeast autolysate) as a
source of vitamin B1. Channon has calculated that this amount of
marmite provides 1.75 mg. of choline per rat per day, a by no means
negligible quantity, and, in addition to providing B1, it must furnish
considerable amounts of other members of the complex. These dif-
ferences in basal diets probably account for the quantitative discrep-
ancies in results from the Toronto and Liverpool laboratories, and
for the general tendencies for the presence of higher liver fats
reported from the former laboratory. Best's animals on the above
diet were definitely undernourished and consistently lost weight.
Workers at this time were on the horns of a dilemma, having to
make a choice between a basal diet which would prevent a loss in
body weight but which contained unknown factors, and a diet whose
constitution was better known but which resulted in undernutrition.
As will become dear in a later section of this paper, it should be
possible at the present time to avoid both these undesirable
alternatives.
Lipotropic effect of proteins and amino acids
The first evidence that protein affected the deposition of fat in
the liver was obtained by Best and Huntsman"5 in 1935 when they
found that the amount of liver fat in rats fed on a diet containing
20% casein and 80% sucrose did not increase as much as when
sucrose alone was given. In the same year Channon and Wilkin-
son,8" in an attempt to produce fatty livers under conditions in which
no loss of body weight occurred, raised the caseinogen content of
their diet to 20%, the fat content remaining at 40%, and found that
fatty livers were not produced. Pursuing this line of investigation
they found that the amount of fat appearing in the liver depended
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on the amount of protein in the diet irrespective of the cholesterol
content. A diet containing 40% fat and 5% casein was found to be
adequate for weight maintenance and for the production of fatty
livers. These results were confirmed in the "cholesterol" fattyliver
where the increase of casein from 5 to 30% prevented the increase
in liver glycerides but did not prevent the increase in cholesteryl
esters. Later, Best and Ridout20 found that if the dietary casein
was increased to 50% the cholesterol fraction fell to normal values.
This was in agreement with the comparative lipotropic effect of
choline on glyceride and cholesteryl ester fractions. By the use
of graded protein percentages in the diet Beeston et al.8 were able
to produce "cholesterol" fatty livers of widely varying compositions.
The next step in the development of the study of the lipotropic
action of proteins came from the finding by Beeston and Channon7
that the addition of cystine to a diet low in protein (5%) and high
in fat caused an 87% increase in the fat content of the livers of rats.
Furthermore, they found that there was no relationship between the
amount of cystine fed (3.25 to 80 mg. daily) and the extent of the
effect. This lipotropic effect of dietary protein was confirmed by
Best et al.,"2 and the cystine effect by Tucker and Eckstein.90 In
addition, these latter workers made the surprising discovery that
whereas the addition of 0.5% cystine to a diet low in protein and
high in fat caused an increase of 57% in liver lipids over the controls
lacking the cystine, the addition of 0.5% methionine to the same
diet caused a decrease of 41 % below that obtained when methionine
was omitted. Thus, the two sulfur-containing amino acids of pro-
teins were found to have opposite effects on lipid deposition in the
livers of rats. The lipotropic action of methionine was confirmed
by Channon et al.,29 who made the additional observation that an
intake of 20 or 40 mg. of methionine daily had no preventive effect
when the fat in the liver of control animals was of only moderate
intensity (approximately 15%o), but that an intake of 40 mg. was
effective when the fattiness was more intense (24%). They found
also that methionine decreased the deposition of glycerides as well
as of free and esterified cholesterol in "cholesterol" fatty livers.
Best and Ridout22 investigated the lipotropic activities of d- and
l-methionine and of the racemic mixture and found them to be ofthe
same order.
An extension of these studies to mice was made by Singal and
Eckstein,87 who found that these animals behaved similarly to rats
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when given a diet high in fat and low in protein. The experiments
cited above on the lipotropic action of proteins were carried out with
casein as the protein used, and Singal and Eckstein obtained results
with mice which were in agreement with those in rats in that they
found that an increase in the casein of the diet from 5 to 20% caused
a marked drop in liver lipids. They observed also that where
arachin, a protein which is low in methionine, was used in place of
casein an increase in its content from 5 to 20% had no effect.
Gelatin, which contains relatively little methionine, was found by
Best et al."2 to have little, if any, lipotropic action. Channon et al.27
investigated the lipotropic action of a number of different choline-
free proteins, with the following results in order of decreasing
intensity-whale muscle protein, caseinogen, albumin, beef muscle
protein and edestin, fibrin and gliadin, and lastly gelatin and zein.
In contrast to the results of Best, they found that gelatin, possessed
some action. In general, the lipotropic action decreases as the
methionine content decreases, the data for the latter estimations being
obtained from the determinations of Baernstein,4 who has investi-
gated the methionine content of a number of proteins.
By this time it appeared to be clearly established that methionine
was the constituent of protein which accounted for the lipotropic
activity and which was able to replace choline in the prevention and
cure of dietary fatty liver in the rat. It was found to be less active
than choline, and in 1938 Channon et al.29 calculated its activity to
be about one-twelfth that of choline, a figure which was later30
revised to one-fifth. That there was any direct relationship in the
animal body between choline and methionine other than their simi-
larity of action on liver lipids appears not to have been suspected
until 1939 when Du Vigneaud et al.41 found that homocystine was
unable to replace methionine for growth in rats, but could do so if
choline was added to the diet. This suggested that choline was able
to furnish methyl groups to homocystine to form methionine. That
the reverse process could occur-that is, the transfer of methyl
groups from methionine to choline-was shown by Du Vigneaud
et al.39 when they fed methionine containing deuterium in its methyl
group to rats on a methionine-choline-free diet and were able to
isolate from the body tissues choline containing deuterium in its
methyl groups. The lipotropic action of methionine is apparently,
then, attributable to its ability to transfer methyl groups to choline.
In the meantime, evidence was beginning to accumulate that the
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action of proteins on fatty livers could not be accounted for com-
pletely by the cystine and methionine contents. Tucker and Eck-
stein9' found that the addition of 0.5% cystine to a diet containing
40% lard and 5% casein greatly increased the deposition of liver
lipids, whereas a similar addition to a diet in which the casein was
replaced by gliadin had little if any effect. The cystine-casein diet
contained per 100 gm. of food 566 mg. of cystine and 177 mg. of
methionine, whereas the cystine-gliadin diet contained 637 mg. of
cystine and 102 mg. of methionine. If cystine and methionine were
the only determining factors one would expect the livers of the
animals on the gliadin diet to contain more fat, a speculation which
is contrary to the experimental results. Similar results with respect
to the cystine effect were obtained by Channon et al.,30 who found
that cystine added to basal albumin diets caused no further increases
in liver fat. This is in contrast to the effect of adding increasing
amounts of cystine to a basal casein diet where up to a point there
is an increasing amount of fat in the liver. The differences are
probably due to the fact that casein is very low in cystine whereas
albumin and gliadin contain appreciable amounts. There appears,
then, to be a maximum effect which cystine is able to exert on liver
lipids, and in a later section of this paper a possible explanation will
be offered.
Further disquieting evidence against the cystine-methionine
explanation is seen in the finding of Channon et al.27 that albumin,
which contains somewhat more methionine than does casein, is
slightly less effective in its lipotropic action than is casein.* In addi-
tion, they observed that the influence of the various protein supple-
ments on liver fat depended somewhat on the amount and nature of
the basal protein used, some being more active when casein was the
basal protein and others when casein was replaced by albumin.
Best and Ridout22 present further data which have similar implica-
tions. They added 30% casein to a diet containing 5%o meat
powder as the basal protein and got the expected decrease in liver
fat, but if they added to the basal diet cystine and methionine in
amounts corresponding to those supplied by the diet containing 30%7"
casein they found little or no decrease in liver fat. They found
further that while relatively small doses of methionine (0.5% of
* It should be noted that the Liverpool workers have here for the first time
omitted marmite from their basal diet and have replaced it with aneurin as the source
of vitamin B,.
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the diet) produced a significant fall in liver fat, an increase to 2%7o
in the amount ingested in the diet caused no further decrease in spite
of the fact that large amounts of fat were still present in the liver.
In contrast to this, increasing amounts of dietary casein or choline
decreased the liver lipids to a normal level. Similar findings were
reported by Channon et al.30
In the light of our present knowledge the experiments of all
three groups of workers, in the laboratories of Best, Channon, and
Eckstein, may be criticized on the basis of the uncertain nature of
certain of their basal dietary constituents. Best uses his meat
powder, Channon adds marmite, and Eckstein adds dried yeast.
However, the fact that despite variations in working conditions these
groups of workers, the outstanding investigators in the field, agree
that the cystine and methionine contents are not able alone to account
for the lipotropic action of proteins, forces one to agree with them
until contrary evidence is advanced. Channon offers two possible
explanations for the limited lipotropic action of methionine; either
methionine acts independently of choline, which seems highly
improbable from the results of Du Vigneaud, or some factor other
than the provision of methyl groups may be the limiting factor on
the rate of choline synthesis. The outline of an experiment which
should test the validity of this second alternative will be given in the
last section of this paper.
The lipotropic action of other amino acids has been investigated.
Beeston and Platt9 found alanine, arginine, aspartic acid, histidine,
hydroxyproline, leucine, lysine, proline, and valine all to be inactive,
whereas tyrosine possessed slight activity. Leucine, isoleucine, and
valine were found bv Singal and Eckstein88 to be without effect on
liver fat.
Certain compounds related to the sulfur-containing amino acids
have been studied. Both homocystine and cysteine as supplements
to a diet which is free of choline, low in protein, and high in fat act
like cystine, accordingto Singal and Eckstein.87 This effect ofhomo-
cystine is interesting because this compound is formed from meth-
ionine which in turn has been shown to contribute its methyl group
to choline. Thus, the opposed effects of the two products of the
demethylation of methionine on liver lipids may partially account
for certain of the unexplained reactions of methionine. It is also
possible that the action of homocystine might be readily overcome
by the increasing amounts of choline which are formed. It has been
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found that the next higher homologues of cystine, pentocystine and
hexocystine, are without effect. That methyl groups are concerned
in lipotropically active substances is indicated by the observation of
Singal86 that the betaine of cystine prevented the accumulation of
fat in the liver of mice, whereas oxidation of cystine to cystine disulf-
oxide did not alter the property of causing the accumulation of liver
fat. Further oxidation to cysteic acid resulted in a loss of activity.
Lipocaic
In 1936 Dragstedt et al."7 postulated the existence of a new
hormone in the pancreas which they termed "lipocaic," which per-
mitted survival and prevented and relieved the fatty degeneration
and infiltration of the livers of depancreatized dogs. Ever since
that time the existence or non-existence of lipocaic has been a lively
topic and the object of much experimental work.
Van Prohaska, Dragstedt, and Harnes92 observed that the fatty
degeneration and infiltration of the liver which appeared in depan-
creatized dogs maintained with insulin was not due to the absence
of pancreatic juice from the intestine since it did not occur in dogs
provided with total pancreatic fistulae or in dogs after ligation of
all the pancreatic ducts, nor was the beneficial effect of raw pancreas
due to the external secretion of the pancreas since the administration
of fresh pancreatic juice had no such beneficial effects. As will be
pointed out later in this paper, Chaikoff has obtained results com-
pletely opposed to all of these of Dragstedt. Dragstedt8 ruled out
choline as the lipotropic agent present in pancreas on the following
grounds: (1) It requires 2 gm. ofcholine a day for a beneficial effect,
whereas 100 gm. of pancreas, containing only 250 mg. of choline, is
effective. (2) The effect of feeding pancreas is specific. Liver and
brain contain as much or more lecithin and choline but are not bene-
ficial. (3) When extracts of pancreas are made, the active sub-
stance is in the fat-free alcohol fraction,* whereas the ether-soluble
fractions, which contain almost all the lecithin, are inactive. (4) It
has been possible to secure an extract from pancreas which exerts a
typical effect with from 60 to 100 mg. daily. This material is free
of fat and contains only 1 to 2% free choline. In criticism of the
above, point (2) may be immediately ruled out because of the high
* It is the fat-free alcohol fraction mentioned here which is the lipocaic prepara-
tion used in the experimental work.
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content of cholesterol in the brain and the well-known ability of this
compound to cause fatty livers, and because of the recent discovery
by McHenry and Gavin7" that the feeding of a liver extract causes
the development of fatty liver irrespective of the cholesterol content.
Dragstedt et al.38 describe the following symptoms as signs of
lipocaic deficiency which may be present in 4 to 6 weeks after pan-
createctomy in dogs maintained with insulin: decrease in appetite and
activity, decreased glucose excretion, decrease in insulin requirements
with occasional hypoglycemic convulsions, impaired liver function as
evidenced by abnormal retention of bromsulfalein, and decrease in
concentration of blood lipids. All these functions may be restored
to normal by the administration of lipocaic. Dragstedt38 suggests
that the action of lipocaic in increasing glucose excretion and insulin
tolerance as well as in decreasing liver lipids may be through the
conversion of fat to carbohydrate. This does not appear to be a
valid deduction, as the administration of lipocaic appears to repair
liver function in general as well as to improve the appetite and
general nutritional state of the animal.
Dragstedt's work has been criticized for the method of assay
used. This method consisted of histological examination for fat
content of biopsy samples of the liver taken before and after the
feeding of pancreatic fractions. Chaikoff and Kaplan26 showed that
the increased lipid content of the liver in the depancreatized dog is
not deposited uniformly throughout the organ, but varies extensively
from lobe to lobe. A further criticism of Dragstedt's procedure is
in his use of histological rather than chemical methods of determin-
ing fat content. Dragstedt et al.38 consider that they have answered
this criticism satisfactorily by comparative chemical and histological
methods of estimating fat in the liver and finding the correlation
between the two to be good. They found, further, that the differ-
ences in fat content from lobe to lobe were so slight as to be of no
significance in interpreting the effects of deprivation of lipocaic.
At this point we may examine in some detail the experimental
evidence upon which Dragstedt bases his conclusions. We shall con-
sider in a later section his studies on ligation of the pancreatic duct,
limiting the present comment to his work on the depancreatized dog
maintained with insulin. From one experimental animal he drew
the conclusion that 25 gm. of raw pancreas a day (that is, containing
about 60 mg. of choline) were sufficient to relieve the fatty infiltra-
tion in one month's time. No accurate quantitative estimations of
238LIPOTROPIC SUBSTANCES
improvement were possible with his method of assay. This small
content of choline was contrasted with the findings of others that
from 1.5 to 2 gm. of choline were required. Clearly, Dragstedt
was not justified in drawing from one experimental animal his
broad conclusion that the effect of raw pancreas is not due to its
choline content. Similarly, from a study of 4 experimental animals
which were given 4 different amounts of choline daily he concluded
that 1 gm. of choline daily was sufficient to improve the condition of
the liver. Unfortunately the one animal which showed the signs of
improvement died of pneumonia two weeks after the first slight
signs of improvement were noted!
On the other hand, the experiments of Dragstedt on the effects
of his fat-free alcohol extract, the lipocaic preparation, are very con-
vincing. He gives the protocols for S dogs in which the daily feed-
ing of 1.5 gm. of his extract (the amount obtained from 100 gm.
of pancreas) caused marked improvement in the fatty liver of all
the animals, in some cases as early as within 3 weeks, and in
some cases there was almost complete recovery as the period was
extended. He observed 9 additional dogs which he reports as show-
ing improvement similar to those whose histories were given in
detail, so that he had 14 animals, all acting uniformly, on which to
base his conclusions. He did not determine the choline content of
his preparation at that time, but it is obvious from later investigations
of his own and of others that choline could not have accounted for
his results. The questionable part of Dragstedt's conclusions lies
not in his postulation of the existence of a lipotropic component in
his pancreatic extracts, but rather in his hypothesis that this compo-
nent is a hormone. The evidence on which he based this conception
was obtained from his results after ligation of the pancreatic ducts.
This will be discussed in detail in the next section.
At about this same time (1935-37) Chaikoff and Kaplan2' 58, 59
were conducting studies similar to those of Dragstedt. They were
highly critical of Dragstedt's work, especially of his methods, but
curiously enough have arrived at essentially the same conclusions.
The great difference between their results and those of Dragstedt is
in the time factor. Whereas Dragstedt obtained his curative effect
with raw pancreas within a month, Chaikoff and Kaplan found that
a period of from 10 to 12 weeks was required to get such an effect
from the daily ingestion of either 2 gm. of choline or 250 gm. of
raw pancreas (containing from 600 to 700 mg. of choline). This
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seems a minor point and one is willing to concede Chaikoff's time
factor as the more likely one in view of the larger number of experi-
mental animals used. Chaikoff and Kaplan were interested in the
blood lipid level as well as in the liver lipid content of depancrea-
tized dogs maintained with insulin. They found that the ingestion
of raw pancreas raised the level of the blood lipids and decreased
the level of the liver lipids, but when the pancreas had been auto-
claved its influence on the level of blood lipids was lost whereas its
action on liverlipids remained. Thus, theyestablished the existence
of heat-labile and heat-stable fractions in raw pancreas. Choline
was found to have no effect on the blood lipid level and therefore
is not the heat-labile fraction, whereas choline does decrease liver
lipids and therefore may be the heat-stable component. In a recent
paper Entenman and Chaikoff42 have done much to clarify the above
findings. They present evidence which indicates, in agreement with
Dragstedt, that choline is not the only factor involved in the lipo-
tropic activity of pancreas. They found that 300 mg. of choline a
day were sufficient to prevent the development of fatty livers in
depancreatized dogs maintained with insulin. (It will be observed
that the preventive dose is considerably smaller than is that required
to cause a cure.) Similarly, 250 gm. of raw pancreas were found
to be able to prevent fatty livers and this amount contained sufficient
choline to account for its lipotropic properties. The authors con-
sider that choline is very probably the heat-stable fraction referred
to above. But, more important, Chaikoff andKaplan have prepared
a fraction of pancreas, designated as "Fraction AR," which is lipo-
tropically active even though its activity cannot be explained by its
choline content, which is at most only 13 mg. per gm. Their frac-
tion AR is the residue resulting from several extractions of pancreas
with acetone and ether. It is destroyed by heat, and is probably the
heat-labile fraction already referred to. The authors do not give
its effect on blood lipids. Their interpretation of this, their latest
finding, will be given later in connection with their findings on the
lipotropic effects of the external secretion of the pancreas.
Reference should be made here to studies on the effect of lipocaic
on the dietary type of fatty liver though it should be kept well in
mind that the physiological differences between a depancreatized dog
maintained with insulin and on a high-protein diet and a "normal"
rat on a diet high in fat and low in protein are so great that the
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findings in one group can be applied to the other only with the
greatest reservations.
Shapiro and Wertheimer85 reported that a pancreatic extract pre-
paredaccording to Dragstedt's procedure caused a decrease to normal
values of the high liver fat of rats which had been on a diet high
in fat and low in protein. Similarly prepared extracts of spleen,
brain, or muscle were without effect, and the authors believe that
the amount of choline in the pancreatic extract could not have been
sufficient to cause this effect. Similarly, Channon et al.,28 using a
pancreatic extract comparable to though not identical with that of
Dragstedt, found that the choline present could account for only
one-third of the total activity of the extract, nor did the protein
present account for the non-choline activity. They conclude, there-
fore, that there is present in pancreas a substance other than choline
involved in fat deposition in the liver.
On the other hand, Aylward and Holt3 fed raw pancreas to rats
with dietary fatty livers and found no effect other than that to be
accounted for by its choline content. In criticism of their work it
might be noted that in almost all cases their liver fat percentages
were not sufficiently high for adequate comparisons of choline and
pancreas to be made, and further, that their conclusions are based on
percentages of fat in the liver, taking no account of liver size.
MacKay63 and MacKay and Barnes"4 administered pancreatic
extracts, prepared according to Dragstedt, to rats with dietary fatty
livers and conduded that the lipotropic activity could be accounted
for on the basis of the choline and protein contents. Their conclu-
sions are not strictly warranted because they did not determine the
choline content of their extract, although they did rule out the
effect of the protein. Similar conclusions were reached by Best and
Ridout,2" who added to the basal diet of rats with fatty livers I gm.
daily of pancreas and found no effect other than could be explained
by the choline andprotein contents. These authors further observed
that liver was as effective as was pancreas. They also tested a
sample of lipocaic, reported bv Dragstedt to be potent in depan-
creatized dogs, and found its lipotropic effect in rats to be that which
was predicted from its choline and protein content. In view of these
conflicting results a decision on the lipotropic action of pancreatic
extracts on dietary fatty livers must await further investigations.
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Lipotropic action of paiwreatic juice
In an attempt to determine the cause of fatty infiltration of the
liver of depancreatized dogs maintained with insulin, Dragstedt
made observations on 7 dogs in which total pancreatic fistulae were
prepared. Of the 7, 3 developed infections and were discarded,
while the other 4 were killed after from 4 to 6 weeks, and examina-
tion of their livers showed no fatty infiltration. In 3 other animals
ligation of the pancreatic ducts resulted in a loss of weight and death
within 6 to 12 weeks. Autopsy revealed slight fatty infiltration
in two cases, but in the third the liver was normal. Nine depan-
creatized dogs maintained with insulin were given daily from 100
to 1000 cc. of pancreatic juice from-normal animals. Of these, 8
died within 3 to 20 weeks and at autopsy showed extreme fatty infil-
tration of the liver, and the ninth also developed a fatty liver as
revealed by biopsy. As a result of the above data, Dragstedt
exduded the external secretion of the pancreas as being at all con-
cerned with the lipotropic action which resulted from the feeding of
raw pancreas.
In 1938 Ralli et al.84 reported that ligation of the pancreatic
ducts of dogs for periods of from 13 to 15 weeks produced fatty
changes in the liver which were indistinguishable from those of the
depancreatized dog. They suggest that the relatively short period
of survival of Dragstedt's animals may account for the discrepancy
between his results and their own. Results essentially similar to
those of Ralli were reported in the following year by Chaikoff and
his collaborators,74 who found that dogs examined at intervals of
12 to 24 weeks after duct ligation exhibited fatty livers regardless
of whether the dogs showed marked, slight, or no loss in body
weight. They43 found also that this treatment caused a fall in
blood lipids which resembled in all details that found in depan-
creatized dogs maintained with insulin. Autopsy revealed marked
atrophy of the pancreas. Addition of raw pancreas to the diet
prevented the fall in blood lipids and fat deposition in the liver.
Entenman, Montgomery, and Chaikoff45 showed further that the
administration of 2 gm. daily of choline completely prevented the
appearance of fatty livers in the duct-ligated dogs, whereas, although
the lipid level of the blood responded somewhat to choline, this
amount failed to restore the concentration completely to normal.
The next development in the study of the effect of the external
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secretion of the pancreas came with the reports of Chaikoff et al.44'
"
on the effect of the daily administration of from 300 to 900 cc. of
pancreatic juice from normal dogs on the blood lipid level of the
depancreatized dog maintained with insulin. They found that when
such treatment was commenced as soon as subnormal lipid values
were established, and was continued for 3 weeks, the blood lipids
rose to a level above normal. That is, the effect was similar to
that resulting from the administration of 250 gm. of raw pancreas
daily, but was unlike that resulting from treatment with choline or
autoclaved pancreas, neither of which caused an increase to even
a normal value in the blood lipid level. The results of the adminis-
tration of pancreatic juice on the liver lipids of depancreatized dogs
maintained with insulin and on duct-ligated dogs are reported by
Montgomery et al.76 77 They found that the administration of
400 cc. daily of pancreatic juice to either of these two types of
experimental animal completely prevented the accumulation of fat
in the liver.
Thus, we see that the results of Dragstedt on the one hand and
of Ralli and Chaikoff on the other are diametrically opposed. In
criticism of Chaikoff's work it should be noted that in the period
between pancreatectomy and commencement of treatment with pan-
creatic juice the dogs were fed 125 gm. of raw pancreas daily until
a vigorous appetite appeared, a period which varied from 3 to 8
weeks, and the animals remained remarkably healthy throughout the
experimental period. This is in contrast to the decreased appetite
which Dragstedt considers to be one of the cardinal symptoms of
lipocaic deficiency. The possibility remains that Chaikoff's animals
were storing the active factor somewhere in the body. On the other
hand, the number of Dragstedt's experimental animals was small
and their survival period short.
On the whole, Chaikoff's results are convincing and, if accepted,
mean that the external secretion of the pancreas must play some
role in the lipotropic activity of the pancreas. Such a view would
not be in disagreement with what appears to be Dragstedt's most
satisfactory experiments, that is, those in which he demonstrated the
lipotropic activity of his lipocaic preparations. It is conceivable that
the active component of the fraction AR of Chaikoff,42 mentioned
earlier, may be identical with the active component of Dragstedt's
lipocaic preparation, in which case the only difference in the opposing
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views would be in the mechanism of transmission of the active sub-
stance away from the gland.
Montgomery et al.76 suggest that the mechanism of the lipotropic
action ofthe pancreas maybe somewhat as follows: the "liver factor"
is absorbed after the pancreatic juice is poured into the intestine, but
whether in an unaltered form or after interaction with the intestinal
mucosa or some dietary constituent cannot be answered. They
further suggest the possibility that the pancreatic juice may be only
indirectly involved, and that some substance in the lumen or mucosa
may be acted upon by the pancreatic juice to produce the active
factor.
Hemorrhagic degeneration of the kidney
An interesting development in connection with the study of
lipotropic substances came with the discovery in 1939 by Griffith and
Wade49' 5' 5 that young male rats on a diet high in fat and low in
choline developed severe hemorrhagic degeneration of the kidney in
addition to the development of fatty liver. This hemorrhaglc
degeneration was prevented by choline, methionine, and betaine,'0' 52
and was aggravated by cystine and cholesterol. It may seem sur-
prising that these kidney lesions were not observed by earlier investi-
gators working with low choline diets until one notes that Griffith
used young rats weighing 30 to 40 gm. and from 21 to 26 days of
age as his experimental animals whereas the investigations in the
laboratories of Best and of Channon were made on rats of about
200 gm. in weight. Griffith has shown that the renal deficiency is
less severe if the rats are over 30 days of age, and further that the
effects are less pronounced in the young female rat than in the male
of the same age. Thus, there appears to be a direct relationship
between the rate of metabolism or growth and the need for choline.
Griffith50 has suggested that this relationship may account for his
observation that increasing the amounts of cystine in the diet beyond
a certain point has no further effects on hemorrhagic degeneration,
and for a similar finding by Channon et al.30 on liver lipids, which
has alreadybeen discussed. He argues that the first effect of cystine
added to the previously cystine-deficient diet is to rectify this cystine
deficiency, which improves the nutritional state of the animal and in
turn increases the body's requirement for choline, so that the
so-called cystine effect may be merely a manifestation of shortage of
choline. Once the cystine deficiency has been met further additions
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have no effect. This same explanation could account for the cystine-
like action of homocystine on liver fat because this compound can be
converted into cystine by the body. In support of this idea is the
statement of Griffith5' that he has obtained evidence that an 18%
casein diet is significantly improved by the addition of cystine. Still
further supporting evidence is suggested in a report that the addition
of cystine to a diet containing choline results in a more pronounced
lipotropic effect than if the cystine is withheld. One awaits further
developments in this field.
Mechanism of action of choline
The discovery by Best and Huntsman"4 that choline prevents the
development of fatty livers has been interpreted as meaning that
choline exerts its effect by enabling lecithin synthesis to occur. Such
a hypothesis readily followed from the conception of Leathes, sup-
ported by the subsequent work of Bloor and more recently by Sin-
clair, that lecithin plays an important part in the metabolism of fatty
acids. The consistent finding of all investigators, that while choline
decreases the glyceride and cholesterol fractions of the fatty liver
and exerts no effect on the total content of the phospholipid fraction,
does not necessarily mean that it is not concerned with phospholipid
metabolism. The first experimental evidence that such actually was
the case was presented by Welch,93 who found that the arsenic
homologue ofcholine was as effective as choline in preventingdietary
fatty liver. He fed rats a diet high in fat and low in choline but
containing a supplement of arsenocholine, and at the end of 3 weeks
isolated the lecithin from the brains and livers and found that it
contained arsenic.
Very valuable contributions in this field have been made by
Perlman and Chaikoff, who used radioactive phosphorus as an indi-
cator of phospholipid metabolism. By feeding choline to rats which
had been on a diet high in fat and low in choline accompanied by a
subcutaneous injection of sodium phosphate containing radioactive
phosphorus, they78 were able to show that choline speeds up phos-
pholipid metabolism in the liver. The increased phospholipid
metabolism from a single dose of choline began to appear one hour
after choline ingestion and its effect had disappeared in 10 to 12
hours. Further, they found that the increase in phospholipid
metabolism was proportional to the amount of ingested choline
(between 2 and 30 mg. per rat). They conclude that the increased
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phospholipid turnover is associated with the action of choline in its
sweeping out of fat from the liver. In a later paper80 they found
that betaine acted similarly to choline except that its action was
slower and the dose requirement larger. As will be seen later, this
is in agreement with data from another type of experiment. The
action of dietary cholesterol in promoting the production of fatty
liver was explained by the observation of these same investigators79
that cholesterol decreases the phospholipid turnover in the liver, an
effect which could be demonstrated as early as 30 hours after
cholesterol, and before the effect on the fat content of the liver was
evident. Thus, both the production and prevention of fatty livers
can now be associated with the rate of phospholipid turnover.
When the effect ofdietary protein on thedeposition of liver lipid
had become established and its effect found to be due, partially at
least, to the content of its sulfur-containing amino acids, Perlman
et al.8" were prompted to examine the effects of these amino acids
on the rate of liver phospholipid turnover. So far, the results with
this method, using radioactive phosphorus, had been in complete
agreement with those obtained by other experimental methods, and
this continued for methionine, which has been shown to be lipotropic
and which was shown here to stimulate the rate of phospholipid
turnover in 6 to 8 hours after feeding the amino acid. But cystine
and cysteine, both of which have been shown to promote the deposi-
tion of fat in the liver, were as active as was methionine on the liver
phospholipid. The authors point out that where the effect of cystine
on liver lipid was studied the cystine was fed daily for from 2 to 3
weeks, whereas all studies in their work were made on livers several
hours after a single feeding, and they suggest that it would be of
interest to know whether a single feeding of cystine would have a
lipotropic effect. Here, then, is an intruding exception to the gen-
eral correlation between lipotropic activity and liver phospholipid
turnover. It may be noted here that there are now a number of
indications that cystine may not have the clearly defined effects on
fat metabolism which have been assigned to it, and this should be a
fruitful field for future investigations.
Continuing their use of radioactive phosphorus, Perlman et al.82
studied the effect of a number of additional amino acids. The list
induded glycine, alanine, serine, tyrosine, proline, glutamic acid,
and asparagine, all of which were found to be without capacity to
stimulate phospholipid turnover in the liver. This is in general
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agreement with other experimental findings with the possible excep-
tion of tyrosine which was found by Beeston and Platt' to exert a
very slight lipotropic action.
A different mode of attack on the problem of the mechanism of
action of choline was made by Channon and his group of workers
in Liverpool. They studied the effect on lipotropic action of slight
changes in the choline molecule. It should be mentioned that Best
and Ridout"8 in 1933 observed that the deposition of fat in the rat's
liver produced by feeding cholesterol could be prevented by adding
either choline or betaine to the diet. This was confirmed by Platt,83
in 1939, who found that betaine possessed about 30% of the lipo-
tropic activity of choline. Channon and Smith32 found that triethyl
choline, that is, choline with the three methyl groups replaced by
ethyl groups, was about 70% as active as choline whereas the
tripropyl compound was without effect.3' Homocholine (trimethyl-
y-hydroxy-propyl-ammonium hydroxide), the next higher homo-
logue of choline, was found to be more effective than choline itself.
Choline methyl ether was found to be inactive, indicating that the
body is unable to demethylate this compound, so that this type of
methyl linkage appears not to be involved in Du Vigneaud's system
of transmethylation within the body. Negative results were also
obtained with ethanolamine, so that if choline acts through lecithin
formation, then the cephalins have little or no importance in the
metabolism ofdietary fatty acids. (The recent discovery thatserine
may to a certain extent replace ethanolamine as the nitrogenous com-
ponent of the cephalins probably does not invalidate the above con-
clusion.) Creatine, too, was found to be without lipotropic activity,
a finding in agreement with that of Du Vigneaud et al.,40 that cre-
atine does not enable homocystine to replace methionine for growth
in rats and therefore is unable to enter into transmethylation in vivo.
The lipotropic action of betaine is of interest in connection with
the experiments of Mann and Quastel,6" who demonstrated that the
addition of choline to slices or extracts of rat liver increased the
oxygen uptake, and that the disappearance of choline was accom-
panied by the formation of betaine aldehyde. This compound is
intermediate in the oxidation of choline to betaine. Assuming the
whole reaction to be reversible, Platt83 suggests that betaine may act
in the body by being first converted into choline. Perhaps a more
plausible explanation, in view of so much evidence, would be that
betaine acts as a contributor of methyl groups. This would be in
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agreement with the observation of Singal86 that the betaine of cystine
exerts a lipotropic action.
The question as to whether choline has an effect on the oxygen
consumption of fatty livers has been studied by Welch, Irving, and
Best,94 who found that the oxygen consumption of slices of fatty
livers was less than was that of the livers which had been fatty but
whose fat content had been reduced by the administration of choline
to the animal. This does not necessarily mean that choline increases
oxygen consumption, but can be explained if we assume that the
stores of fat are not active tissue, a point raised by Best and Ridout.23
These authors further point out that this raises the problem as to
whether the accumulation of fat causes the loss of function or
whether the loss of function is the primary disturbance, a question
which still remains unanswered.
Using a completely different approach, Deuel et al."5 have con-
cluded that choline does not increase the rate of fat oxidation, taking
increased ketonuria during fasting as a measure of increased fat oxi-
dation. They found that the level of ketonuria was lower during
the first two fast days and higher during the following three fast
days in rats previously on a choline-butter-fat diet than in those
on a butter-fat control diet. This they explain by saying that while
choline does not increase the rate of fat oxidation and does prevent
the deposition of labile fat in the liver, which would account for the
early decreased ketonuria, it has no such effect on deposition in the
tissues, so that in subsequent fasting such fat is transferred to the
liver, thus accounting for the later increased ketonuria. This con-
clusion, that choline does not increase fat oxidation, was confirmed
by MacLean, Ridout, and Best,65 who found that rats with fatty
livers excrete during starvation larger amounts of ketone bodies
than do normal rats, but they observed that the extent of ketonuria
was not proportional to the amount of excess fat in the liver.
Vitamin-B complex* and fatty livers
Recently, the picture of the effects of various dietary constituents
on liver and body fat has been greatly complicated by the findings
of McHenry, who has studied the influence of different components
of the vitamin-B complex. To date, almost every member of the
complex has been shown to be involved, and although at the present
* In this paper, choline is not included in the term "vitamin-B complex."
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time the effects are not clearly defined, it is highly probable that
future work will allow an explanation of certain discrepancies in
earlier results on the basis of the dietary vitamin B content.
Comment on the effects of vitamin-B complex cannot be confined
to the liver fats because the effects on body fat depots are inextricably
involved. MacLean, Ridout, and Best65 had shown that choline
caused a gain in weight of animals which had previously been on a
choline-free diet, and they suggested that its presence in the diet
favored the normal distribution of fat between the liver and body
depots. McHenry67 68 found that on a diet high in fat and low in
protein and choline, the addition of vitamin B1 caused an increase
in both body and liver fat of rats over that of controls lacking B1.
The increase in body weight which occurred was not due solely to
increased food intake because the effect was still secured when the
food intake was limited, and, further, since both body and liver fat
were increased, the one could not have been at the expense of the
other. When choline was added to the above diet the body weight
increased, a finding in agreement with that of Best mentioned above,
whose basal diet included a supplement of vitamin B,. McHenry
found further that if choline was present in the diet, the effect of
thiamine (vitamin B1) on liver fat could not be obtained. These
observations led him to the conclusion that whereas thiamine and
choline exert complementary effects on body weight (which he
showed was on body fat), they have antagonistic effects on liver fat.
A sparing action of thiamine on fat was also observed by McHenry.
When B1 was included in the diet, the amount of fat necessary to
maintain optimum body weight was less than when the diet was free
of B1, and conversely, when the diet was low in fat the requirements
for thiamine were higher. The thiamine-sparing action of fat has
been observed by other investigators. Among these are Arnold and
Elvehjem,2 who found that increasing the fat content of a low-fat
diet to 57% by isocaloric replacement of sugar reduced the thiamine
requirement to one-third that of the low-fat diet. In a later paper,
Longenecker, Gavin, and McHenry6" demonstrated that the addi-
tional fat deposited in the liver and tissues under the influence of
thiamine was not due to an increased absorption of fat from the
intestine by finding that the same effects were obtained when the
animals were fed on a diet free of fat. All these findings have led
McHenry to the conclusion that thiamine is concerned in the con-
version of carbohydrate to fat in the body. The mechanism of
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action of thiamine in the formation of fat from .carbohydrate allows
some interesting speculation. If the conversion occurs through
pyruvic acid as an intermediate, a role can be assigned to vitamin B,
in the process because it is now recognized that diphosphothiamine
plays an important part in the metabolism of pyruvic acid in the cell.
Barron' has suggested the possibility that diphosphothiamine may
act by forming the integral part of the activating protein of the
enzyme systems concerned with the activation of pyruvate. The
fact that thiamine increases both body and liver fat is further evi-
dence that it promotes the synthesis of fat rather than simply mobil-
izing it. The antagonistic and complementary effects of thiamine
and choline on liver and body fat respectively could be explained,
according to McHenry's postulation, by saying that thiamine causes
the formation of fat from carbohydrate in the liver whereas choline
mobilizes it via phospholipid from the liver to the depots.
The action of vitamin B2 (riboflavin) on fat metabolism was
investigated by McHenry and Gavin,70 and was observed to be with-
out effect on liver or body fat when fed to rats or pigeons as the
only supplement to a diet high in carbohydrate and free from fat,
but in conjunction with thiamine it caused a further increase in
liver fat.
The next member of the vitamin-B complex to become impli-
cated in the process of fat metabolism was B6 (pyridoxine). Halli-
day"5 had noted in 1935 that a diet deficient in vitamin B6 caused
the production of fatty livers. Three years later McHenry and
Gavin"9 observed that the body fat of rats was increased out of pro-
portion to the increased food intake by the supplementation of a
diet containing thiamine and riboflavin with a rice-polish concen-
trate, a preparation containing, among other factors, large amounts
of vitamin B6. Last year this same group of workers,47 able now
to obtain crystalline pyridoxine, found that the administration of the
pure vitamin BR in conjunction with thiamine, riboflavin, and choline,
to rats on a fat-free diet caused a slight increase in body fat, and this
increase was slightly augmented by the further addition of nicotinic
acid. This action of nicotinic acid, of increasing the body neutral
fat, has been confirmed by Forbes,46 who observed also that nicotinic
acid had no effect on liver neutral fat, but that there was a striking
increase in liver cholesterol which could be reduced by the adminis-
tration of choline. Thus, in summary, we have vitamin B1 increas-
ing liver and body fat, B2 increasing liver fat, B6 increasing body fat,
and nicotinic acid increasing body fat and liver cholesterol.
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This year McHenry and Gavin'3 have presented evidence which
indicates that pyridoxine is concerned in the conversion of protein to
fat. It had previously been shown that the administration of
thiamine alone of the vitamin-B complex does not cause the synthesis
of fat from protein though it will do so from carbohydrate. It was
found here that the addition of pyridoxine to a high-protein diet
containing B1, B2, and pantothenic acid prevents the reduction in
body fats which occurs with any other combination of the isolated
members of the complex, but lacking pyridoxine.
The most recent addition to the family of B vitamins, biotin and
inositol, also appear to be involved in the picture of fat metabolism.
It will be remembered that Blatherwick et al.24 in 1932 observed the
production of fatty livers after the administration of liver extracts.
He, or rather others following him, attributed the effect to the
cholesterol content, and this led to the development of the study of
the "cholesterol" fatty liver already discussed. Within the past
year McHenry and his collaborators"2 71, 72 have fed an alcoholic
extract of beef livers, which they have shown to be free of chol-
esterol, to rats on a fat-free diet containing supplements of vitamins
B1, B2, and Be, and observed the production of very fatty livers
containing large amounts of cholesterol. The addition of choline to
the diet had only a slight effect on the liver lipids, but the adminis-
tration of lipocaic prevented the condition. The most recent con-
tribution of this group of workers is that of a few months ago,48
when it was found that biotin could produce the same type of fatty
liver under the same conditions as does the liver extract. Further,
they made extracts of liver, kidney, muscle, wheat germ, yeast, and
rice polishings according to the procedure which had been used for
the preparation of lipocaic from pancreas, and found them all to be
as effective as lipocaic in curing the "biotin" type of fatty liver.
Still further, the administration of inositol was found to prevent the
development of this type of fatty liver in a manner similar to that
of lipocaic.
The implications of McHenry's work are great and his results
await confirmation and evaluation by experts in the field of nutrition.
Certain observations by Griffith51 and by Griffith and Mulford52
throw some doubt on the validity of McHenry's interpretations of
his experimental results. These investigators found that the renal
pathology and fatty liver do not occur if there is restriction of the
intake of a food mixture which produces severe damage if given
ad libitum. Further, they were unable to demonstrate any effect
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of supplements of thiamine or pyridoxine on liver fat in experiments
in which these compounds were added to a diet which contained
yeast and which was adequate for growth. These two observations
led Griffith to raise the question as to whether the results of
McHenry really represent direct an,tagonisms of thiamine and
pyridoxine to choline. He suggests that dietary supplements which
improve deficient or even suboptimal diets may appear to act in
direct opposition to choline, whereas such an effect may be non-
specific and have no direct relation to the metabolism of choline
itself.
At this stage in our knowledge of the effects of the vitamin-B
complex on fat metabolism the point which strikes one most force-
fully is the large number of dietary components which may be
involved. Since the effects of some are complementary and others
antagonistic, the final results will depend upon the relative propor-
tions of the various factors. Although most of the experimental
work on lipotropic substances has been carried on with the presence
in the diet of highly variable vitamin components, and therefore
may be criticized on these grounds, it should be remembered that
within any one group of experiments adequate controls were
provided.
Discussion
In reviewing the status of the problem of lipotropic substances
at the present time, one realizes that there remain a number of
unsettled points, some of which would appear capable of experi-
mental test.
Several attempts have been made to identify chemically the
active component of Dragstedt's lipocaic preparation, but these have
been without success. Thedemonstration that inositol has lipotropic
activity similar to that of lipocaic offers a clue as to possible means
of isolation and identification of the lipotropic agent other than
choline which is present in pancreas. Similarly, there exists the pos-
sibility that the active component of Chaikoff's lipotropically active
fraction AR may be inositol.
Another problem which awaits solution concerns the limiting
factor which prevents methionine from exerting its lipotropic effect
beyond a certain point. If methionine exerts its effect by providing
methyl groups for choline, then it must be the ethanolamine com-
ponent of choline which is deficient. A report this year by Stetten89
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contains information which should aid in the settlement of this ques-
tion. Stetten found that if ethanolamine labeled with heavy
nitrogen is fed to rats, the choline of the body, and especially of
the liver, contains the labeled nitrogen. The application of this
observation to our problem would require the feeding of different
amounts of methionine to a group of rats with dietary fatty livers,
thus determining a "maximum dose," beyond which further amounts
of methionine are without effect on liver fat. If the administration
of ethanolamine to animals receiving more than the "maximum
dose" of methionine, and with excess fat in the liver, causes a decrease
in liver fat to a normal level, one may conclude that it is the lack
of ethanolamine which is responsible for the limited lipotropic action
of methionine.
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